No Data
Digital Holdings, Takamizawa Cybernetics, and others.
Digital Holdings Co., Ltd. (Stock Code: 2389) increased its shareholding percentage in Hakuhodo DY Holdings Inc. from 58.70% to 59.89%. The reporting obligation date is February 13, 2026. Takamizawa Cybernetics Co., Ltd. (Stock Code: 6424) decreased its shareholding percentage in Fujitsu Limited from 9.94% to 6.95%. The reporting obligation date is February 16, 2026. Wintest Corporation (Stock Code: 6721) holds a shareholding percentage of abc Corporation at 11.54%, with further details pending.
Companies such as New Tech and Sawafuji Electric
JTP Co., Ltd. (Code: 2488) has reported a change in its shareholding ratio from 13.80% to 0.00%, with the reporting obligation date being April 1, 2021. Janis Industries Co., Ltd. (Code: 5342) has reported no change in shareholding by Maeda Shin, remaining at 0.00%, with the reporting obligation date set for February 13, 2026. New Tech Co., Ltd. (Code: 6734), owned by Kanamot Co., Ltd., has reported a decrease in its shareholding ratio from 7.93% to 0.00%, with the reporting obligation date on February 9, 2026.
FUJI Media Holdings, NewTech, and others.
SBI Holdings' shareholding ratio in Medical Data Vision Co., Ltd. (3902) remains unchanged at 36.24%, with the reporting obligation effective date being February 3, 2026. SBI Holdings' shareholding ratio in FUJI Media Holdings (4676) decreased from 5.12% to 0.23%, with the reporting obligation effective date set for February 5, 2026. Additionally, SAKSA Corporation holds a shareholding ratio in New Tech Co., Ltd. (6734).
Newtech: Interim Report
Focus is on Nexera and Discharge Precision, while Asmark and BS11 may remain sluggish.
In the U.S. stock market on August 8, the NY Dow rose by 270.03 dollars to reach 49,266.11 dollars, while the Nasdaq Composite Index fell by 104.26 points to close at 23,480.02 points. The Chicago Nikkei 225 futures were up 425 yen from Osaka's daytime trading to reach 51,615 yen. The exchange rate was 1 dollar = 156.80-90 yen. In today’s Tokyo market, Fast Retailing <9983>, which saw a 33.9% increase in Q1 operating profit and upwardly revised its dividend forecast for the fiscal year ending August 2026, and companies with a 41.6% increase in cumulative operating profit for the third quarter attracted attention.
January 9 [Today's Investment Strategy]
[FISCO Select Stocks] [Material Stocks] Nexcella Pharma <4565> at 894 yen (1/8). A drug discovery venture, formerly part of the Sosei Group. The company announced that it has entered into a licensing agreement with SunCell Bio for the development, manufacturing, and commercialization of vamorolone, a treatment for Duchenne Muscular Dystrophy (DMD), in Japan, South Korea, Australia, and New Zealand. The introduction of vamorolone is expected to strengthen Nexcella's position in the rare disease and specialty areas.